Zhiqiu Hu

机构：Fudan University, Minhang District Central Hospital, Obstetrics and Gynecology Hospital of Fudan University · ORCID：0000-0002-3244-1607

发表论文 60 篇 · 总被引 704 次 · h-index 14

代表论文

• LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation (2025 · Cancer Letters · 被引 13)
• WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy (2024 · Journal for ImmunoTherapy of Cancer · 被引 11)
• FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma (2024 · The Oncologist · 被引 10)
• Denoised recurrence label-based deep learning for prediction of postoperative recurrence risk and sorafenib response in HCC (2025 · BMC Medicine · 被引 6)
• The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma (2024 · International Journal of General Medicine · 被引 5)
• Data from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy (2024 · 被引 1)